Oncogenic Ras downregulates mdr1b expression through generation of reactive oxygen species
Semo Jun1, Seok Won Kim2, Byeol Kim1
1Departments of Premedical Sciences, College of Medicine, Chosun University, Gwangju 61452, Korea.
Abstract:
In the present study, we investigated the effect of oncogenic H-Ras on rat mdr1b expression in NIH3T3 cells. The constitutive expression of H-RasV12 was found to downregulate the mdr1b promoter activity and mdr1b mRNA expression. The doxorubicin-induced mdr1b promoter activity of the H-RasV12 expressing NIH3T3 cells was markedly lower than that of control NIH3T3 cells. Additionally, there is a positive correlation between the level of H-RasV12 expression and a sensitivity to doxorubicin toxicity. To examine the detailed mechanism of H-RasV12-mediated down-regulation of mdr1b expression, antioxidant N-acetylcysteine (NAC) and NADPH oxidase inhibitor diphenylene iodonium (DPI) were used. Pretreating cells with either NAC or DPI significantly enhanced the oncogenic H-Ras-mediated down-regulation of mdr1b expression and markedly prevented doxorubicin-induced cell death. Moreover, NAC and DPI treatment led to a decrease in ERK activity, and the ERK inhibitors PD98059 or U0126 enhanced the mdr1b-Luc activity of H-RasV12-NIH3T3 and reduced doxorubicin-induced apoptosis. These data suggest that RasV12 expression could downregulate mdr1b expression through intracellular reactive oxygen species (ROS) production, and ERK activation induced by ROS, is at least in part, contributed to the downregulation of mdr1b expression.
Insights
Oncogenic H-Ras (V12) downregulates mdr1b expression and increases doxorubicin sensitivity in NIH3T3 cells. This effect involves reactive oxygen species (ROS) and ERK activation, suggesting potential therapeutic targets.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- The multidrug resistance gene 1b (mdr1b) plays a crucial role in drug efflux and multidrug resistance.
- Oncogenic mutations in signaling pathways, such as H-Ras, can alter cellular responses to chemotherapy.
- Understanding the interplay between oncogenic signaling and drug resistance mechanisms is vital for cancer treatment.
Purpose of the Study:
- To investigate the impact of oncogenic H-Ras (V12) on rat mdr1b expression in NIH3T3 cells.
- To elucidate the underlying molecular mechanisms, including the role of reactive oxygen species (ROS) and the ERK pathway.
- To explore the correlation between H-Ras expression, mdr1b regulation, and sensitivity to doxorubicin toxicity.
Main Methods:
- Utilized NIH3T3 cells stably expressing oncogenic H-Ras (V12).
- Assessed mdr1b promoter activity and mRNA expression.
- Employed antioxidants (N-acetylcysteine) and NADPH oxidase inhibitors (diphenylene iodonium) to investigate ROS involvement.
- Used ERK inhibitors (PD98059, U0126) to examine the role of the ERK pathway.
- Evaluated doxorubicin-induced cell death and apoptosis.
Main Results:
- Constitutive H-Ras (V12) expression significantly downregulated mdr1b promoter activity and mRNA levels.
- H-Ras (V12) expression correlated positively with sensitivity to doxorubicin toxicity.
- Antioxidant and NADPH oxidase inhibition treatments enhanced H-Ras-mediated mdr1b downregulation and protected against doxorubicin-induced cell death.
- ERK pathway inhibition increased mdr1b promoter activity and reduced doxorubicin-induced apoptosis.
Conclusions:
- Oncogenic H-Ras (V12) downregulates mdr1b expression, at least partly, through ROS production and subsequent ERK activation.
- This mechanism contributes to increased sensitivity to doxorubicin toxicity.
- Targeting ROS production or ERK signaling may represent a strategy to overcome H-Ras-mediated drug resistance.
More Related Videos
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
09:44Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia
Published on: September 5, 2019
Related Concept Videos
The Ras Gene
Ras is a...
MAPK Signaling Cascades
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
